These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2330490)

  • 21. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
    Bozzette SA; Larsen RA; Chiu J; Leal MA; Jacobsen J; Rothman P; Robinson P; Gilbert G; McCutchan JA; Tilles J
    N Engl J Med; 1991 Feb; 324(9):580-4. PubMed ID: 1992319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.
    Sorensen KN; Sobel RA; Clemons KV; Pappagianis D; Stevens DA; Williams PL
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1512-7. PubMed ID: 10817701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole.
    Park DW; Sohn JW; Cheong HJ; Kim WJ; Kim MJ; Kim JH; Shin C
    BMC Infect Dis; 2006 Feb; 6():26. PubMed ID: 16480497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis.
    Thompson GR; Lunetta JM; Johnson SM; Taylor S; Bays D; Cohen SH; Pappagianis D
    Clin Infect Dis; 2011 Sep; 53(6):e20-4. PubMed ID: 21865185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketoconazole treatment of coccidioidal meningitis.
    Graybill JR; Stevens DA; Galgiani JN; Sugar AM; Craven PC; Gregg C; Huppert M; Cloud G; Dismukes WE
    Ann N Y Acad Sci; 1988; 544():488-96. PubMed ID: 3214090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents.
    Robinson PA; Knirsch AK; Joseph JA
    Rev Infect Dis; 1990; 12 Suppl 3():S349-63. PubMed ID: 2330489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group.
    Diaz M; Negroni R; Montero-Gei F; Castro LG; Sampaio SA; Borelli D; Restrepo A; Franco L; Bran JL; Arathoon EG
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S68-76. PubMed ID: 1562698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imidazole therapy of coccidioidal meningitis in children.
    Shehab ZM; Britton H; Dunn JH
    Pediatr Infect Dis J; 1988 Jan; 7(1):40-4. PubMed ID: 3340457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-alpha and interleukin-1 beta in cerebrospinal fluid of patients with coccidioidal meningitis during therapy with fluconazole. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Ampel NM; Ahmann DR; Delgado KL; Galgiani JN; Cloud GA
    J Infect Dis; 1995 Jun; 171(6):1675-8. PubMed ID: 7769317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection of an arterial prosthesis as the presenting manifestation of disseminated coccidioidomycosis: control of disease with fluconazole.
    Schwartz DN; Fihn SD; Miller RA
    Clin Infect Dis; 1993 Apr; 16(4):486-8. PubMed ID: 8513052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
    Stern JJ; Hartman BJ; Sharkey P; Rowland V; Squires KE; Murray HW; Graybill JR
    Am J Med; 1988 Oct; 85(4):477-80. PubMed ID: 2845778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of asymptomatic coccidioidomycosis in patients with rheumatic diseases.
    Bilal J; Kollampare S; Bode B; Lisse JR; Hoover SE; Sudano D; Ampel NM
    Rheumatol Int; 2019 Jul; 39(7):1257-1262. PubMed ID: 31065743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability of long-term fluconazole therapy.
    Davis MR; Nguyen MH; Donnelley MA; Thompson Iii GR
    J Antimicrob Chemother; 2019 Mar; 74(3):768-771. PubMed ID: 30535104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral and oral fluconazole for acute cryptococcal meningitis in AIDS: experience with thirteen patients.
    Stern JJ; Pietroski NA; Buckley RM; Braffman MN; Rinaldi MG
    Ann Pharmacother; 1992; 26(7-8):876-82. PubMed ID: 1504391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of coccidioidal meningitis with voriconazole.
    Cortez KJ; Walsh TJ; Bennett JE
    Clin Infect Dis; 2003 Jun; 36(12):1619-22. PubMed ID: 12802765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coccidioidal meningitis diagnosed by skin biopsy.
    Hamner RW; Baum EW; Pritchett PS
    Cutis; 1982 Jun; 29(6):603-4, 606, 610. PubMed ID: 7105834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid antibodies detected by ELISA against a 33-kDa antigen from spherules of Coccidioides immitis in patients with coccidioidal meningitis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Galgiani JN; Peng T; Lewis ML; Cloud GA; Pappagianis D
    J Infect Dis; 1996 Feb; 173(2):499-502. PubMed ID: 8568322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biofilm on ventriculo-peritoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis.
    Davis LE; Cook G; Costerton JW
    Emerg Infect Dis; 2002 Apr; 8(4):376-9. PubMed ID: 11971770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetration of fluconazole into abscess fluid.
    Kostiuk KA; Pons VG; Guglielmo BJ
    J Antimicrob Chemother; 1994 Oct; 34(4):603-5. PubMed ID: 7868415
    [No Abstract]   [Full Text] [Related]  

  • 40. Posaconazole for chronic refractory coccidioidal meningitis.
    Schein R; Homans J; Larsen RA; Neely M
    Clin Infect Dis; 2011 Dec; 53(12):1252-4. PubMed ID: 21987729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.